Actively Recruiting

Age: 18Years - 90Years
MALE
ID06279260

National Robotics-Assisted Radical Prostatectomy Database: Exploring Learning Curves and Long Term Surgical, Oncological and Patient Reported Outcome Measures

Led by Melbourne Health · Updated on 2024-08-26

10000

Participants Needed

8

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Melbourne Health

Lead Sponsor

P

Peter MacCallum Cancer Centre, Australia

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying prostate cancer treatment outcomes in men undergoing robotic-assisted radical prostatectomy (RARP) in Australia. This observational study aims to gather long-term data on surgical, oncological, and patient-reported outcomes, addressing gaps in current knowledge about the benefits and costs of robotic surgery compared to other methods. The study also explores surgeon learning curves and aims to improve care standards across both metropolitan and rural hospitals. Participants will be men aged 18 to 90 years with localized prostate cancer who receive medical care at participating hospitals. The study collects information through a national database that records surgical details, oncological results, and patient-reported quality of life measures at multiple time points: before surgery, then at 4 weeks, 6 months, 12 months, 24 months, and 36 months post-surgery. This approach allows researchers to analyze trends and differences in outcomes over time. During the study, participants provide consent for their health information to be collected and monitored. Patient questionnaires and clinical data are gathered at specified intervals to assess the impact of robotic surgery on quality of life and cancer control. The primary goal is to develop evidence-based guidelines to help personalize prostate cancer management and support decision-making for patients and healthcare providers nationwide.

CONDITIONS

Brief Title

National Robotics-Assisted Radical Prostatectomy Database

Who Can Participate

Age: 18Years - 90Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals who consent to participate
  • Aged between 18 and 90 years
  • Confirmed diagnosis of localized prostate cancer
  • Receiving medical care at participating hospitals
Not Eligible

You will not qualify if you...

  • Have not undergone robotic surgery for prostate removal or transperineal biopsy
  • No diagnosis of prostate cancer
  • Decline to provide consent for health information collection
  • Under 18 years of age or older than 90 years (implied by inclusion criteria)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Hospital stay of approximately 1 to 2 days

Participants undergo robotic-assisted radical prostatectomy and receive immediate post-operative care.

1 surgical visit and hospital stay

Post-operative Follow-up

Duration - Up to 36 months post-surgery

Participants are monitored with surgical, oncological, and patient-reported quality of life assessments after surgery.

Visits at baseline, 4 weeks, 6 months, 12 months, 24 months, and 36 months post-surgery

Trial Site Locations

Total: 8 locations

1

Ballarat Health

Ballarat, Victoria, Australia, 3350

Not Yet Recruiting

2

Barwon health

Geelong, Victoria, Australia, 3220

Not Yet Recruiting

3

Austin Healthcare

Melbourne, Victoria, Australia, 2084

Not Yet Recruiting

4

E.J Whitten Prostate Cancer Centre, Epworth Healthcare

Melbourne, Victoria, Australia, 3002

Not Yet Recruiting

5

St. Vincent's Private Hospital

Melbourne, Victoria, Australia, 3002

Not Yet Recruiting

6

Western Heath

Melbourne, Victoria, Australia, 3011

Not Yet Recruiting

7

Peter MacCallum Cancer Centre

Melbourne, Victoria, Australia, 3050

Not Yet Recruiting

8

Royal Melbourne Hospital

Melbourne, Victoria, Australia, 3050

Actively Recruiting

Loading map...

Research Team

N

Nathan Lawrentschuk, MBBS,PhD, FRACS

F

Farleigh Reeves, MBBS, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With...

Prostate Cancer

Actively Recruiting

1 location

A Phase 1b Study of 177Lu-PSMA-617 Combined With Liver Direc...

Metastatic Prostate Cancer

Actively Recruiting

1 location

18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Phase III Ac...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Long-term adverse effects after retropubic and robot-assisted radical prostatectomy. Nationwide, population-based study.

Jón Örn Fridriksson, Yasin Folkvaljon, Karl-Johan Lundström...

https://pubmed.ncbi.nlm.nih.gov/28591934